Upload
Featured Recent Articles Topics Login Upload

Search Results for 'Tdf-Ftc'

Tdf-Ftc published presentations and documents on DocSlides.

Switch to DOR-TDF-3TC vs. Continued Baseline Regimen
Switch to DOR-TDF-3TC vs. Continued Baseline Regimen
by dorothy
DRIVE SHIFT. Switch to Doravirine-TDF-3TC versus C...
Switch from TDF to TAF
Switch from TDF to TAF
by easyho
GS-US-292-0109 Study. GS-US-311-1089 Study. . De...
EFFECTS ON RENAL FUNCTION OF A SWITCH FROM TENOFOVIR (TDF)
EFFECTS ON RENAL FUNCTION OF A SWITCH FROM TENOFOVIR (TDF)
by tawny-fly
M Harris, . S Guillemi. , K Chan, B Yip. ,. . M ...
Raltegravir plus Ritonavir-Boosted Darunavir NEAT001/ANRS 143 Trial
Raltegravir plus Ritonavir-Boosted Darunavir NEAT001/ANRS 143 Trial
by matthew167
NEAT001/ANRS 143 Trial. Darunavir/r + Raltegravir ...
Subjects with Renal Impairment Switching from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide Have Improved Renal and Bone Safety through 48 Weeks Study GS-US-292-0112
Subjects with Renal Impairment Switching from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide Have Improved Renal and Bone Safety through 48 Weeks Study GS-US-292-0112
by micah
Tenofovir. . Disoproxil. . Fumarate. to . Tenof...
Retirement Plan Consulting
Retirement Plan Consulting
by oconnor
Overview of Services. Table of Contents. About RPA...
Total Soluble and Insoluble Dietary Fibre Contents of Wild Growing E
Total Soluble and Insoluble Dietary Fibre Contents of Wild Growing E
by alyssa
302 Vol. 32, 2014, No. 3: 302–307Czech J. Fo...
Renal and Bone Safety of
Renal and Bone Safety of
by ashley
Tenofovir. . Alafenamide. . vs. . Tenofovir. ....
Brad Hare Nothing to Disclose
Brad Hare Nothing to Disclose
by beatrice
Kaiser Permanente San Francisco Medical Center. Sa...
Target Date Funds and P
Target Date Funds and P
by unita
lan . S. ponsor Responsibilities. Marcia S. Wagner...
WHO ARV Forecasting Meeting
WHO ARV Forecasting Meeting
by sistertive
Geneva, March 19 - 20 , 2015 1 | Treatment and C...
Phase 2 of new ARVs Fostemsavir
Phase 2 of new ARVs Fostemsavir
by sportyinds
, . prodrug. of . temsavir. . (. attachment inhi...
Evolving Options for HBV Therapy:
Evolving Options for HBV Therapy:
by desiron
Navigating the New Treatment Landscape. Outline. I...
Use of HCV DAAs with HIV Regimens
Use of HCV DAAs with HIV Regimens
by robaut
Sam Lam, . PharmD. Annie Vong, . PharmD. 2/3/2017....
Common Pharmacomistakes in Advanced Illness
Common Pharmacomistakes in Advanced Illness
by tawny-fly
Common Pharmacomistakes in Advanced Illness Opioi...
ACTHIV 2018: A State-of-the-Science Conference for Frontline Health Professionals
ACTHIV 2018: A State-of-the-Science Conference for Frontline Health Professionals
by phoebe-click
ACTIVITY CODE . TD342. Antiretroviral Medications...
Comparative effectiveness of first-line antiretroviral therapy regimens: results from a large real-
Comparative effectiveness of first-line antiretroviral therapy regimens: results from a large real-
by min-jolicoeur
implementation of Dolutegravir. Meireles MV. , Pa...
Tyre Stewardship in Canada
Tyre Stewardship in Canada
by sherrill-nordquist
Presented to . New Zealand . Tyre. Industry Summ...
ID Week Review 2015
ID Week Review 2015
by briana-ranney
Brian R. Wood, MD. Assistant Professor of Medicin...
Switch to DRV/r + RAL
Switch to DRV/r + RAL
by debby-jeon
SPARE . Study. SPARE Study: switch to DRV/r + RAL...
HBV resistance and
HBV resistance and
by calandra-battersby
immune escape . mutants. Anders Boyd, MPH, . PhD....
Comparison of NRTI combinations
Comparison of NRTI combinations
by tawny-fly
ZDV/3TC . vs. TDF + FTC. Study 934. ABC/3TC . vs...
1 Adam O’Neill Leonid
1 Adam O’Neill Leonid
by celsa-spraggs
Reyzin. Boston University. . A Unified Approach ...
Switch
Switch
by lindy-dunigan
from. TDF to TAF. GS-US-292-0109 Study. GS-US-31...
Switching From a Tenofovir
Switching From a Tenofovir
by yael
. Disoproxil. . Fumarate. (TDF)-Based Regimen to...
Prescribing PrEP in Title X Settings
Prescribing PrEP in Title X Settings
by kaison
Erika Aaron, CRNP. Disclosures. Successful Complet...
Switch to DRV/r + 3TC DUAL Study
Switch to DRV/r + 3TC DUAL Study
by jireh
DRV/r 800/100 + 3TC 300 QD. N = 126. N = 123. DRV/...
Kenneth E. Sherman, MD, PhD
Kenneth E. Sherman, MD, PhD
by heavin
Gould Professor of Medicine. Director, Division of...
Update from CROI 2023: Snippets from Seattle
Update from CROI 2023: Snippets from Seattle
by scarlett
Judith S. Currier, MD, MSc. Professor of Medicine....
PRESENTED AT IAS 2021 – the 11th IAS Conference on HIV Science
PRESENTED AT IAS 2021 – the 11th IAS Conference on HIV Science
by bency
|18-21 JULY 2021. Weight gain in children and adol...
Stephanie Cox Gilead Sciences
Stephanie Cox Gilead Sciences
by emery
Foster City, CA. ULTRASENSITIVE HIV-1 DRUG RESISTA...
Novel Antiretroviral Studies and Strategies
Novel Antiretroviral Studies and Strategies
by danya
Bob Harrington, MD. University of Washington . Pre...
HEPATITIS B PART 2 DR MEERA G KOOTTUM;
HEPATITIS B PART 2 DR MEERA G KOOTTUM;
by jacey
. TODAY. DIAGNOSIS. TREATMENT. SPECIAL SITUATIONS....
Any PRM at baseline Yes No
Any PRM at baseline Yes No
by lucy
39. 129. 100 . (91, 100). 98 . (95, 100). NRTI PRM...
CROI 2015: Treatment and Cure Highlights
CROI 2015: Treatment and Cure Highlights
by unita
Shireesha Dhanireddy. Robert Harrington. March 17,...
Background Long-term use of antiretroviral therapy (
Background Long-term use of antiretroviral therapy (
by jaena
cART. ) in aged HIV-1-infected individuals could e...
CAB for PrEP for Advocates
CAB for PrEP for Advocates
by hadly
Basics of Injectable Cabotegravir. for HIV Prevent...
218RidruejoEAntiviraltreatmentforchronichepatitisBinrenaltransplant
218RidruejoEAntiviraltreatmentforchronichepatitisBinrenaltransplant
by rose
jhep.2017.05.008 ,inpress.[243]DurantelD,ZoulimF.N...
HIV Transmission PrEP /
HIV Transmission PrEP /
by PeacefulPlace
nPEP. Mark Schweizer, DDS MPH. Director Infection ...
Viral hepatitis Best of ILC 2018
Viral hepatitis Best of ILC 2018
by roberts
About these slides. These slides provide highlight...